Drug intelligence / Profile preview

spectinomycin + lincomycin

Development stage
Unknown
Lead developer
Zoetis
Modality
Small Molecules
Administration
Oral, Injection
01

Overview

Spectinomycin + lincomycin is a fixed-dose combination of two antibiotics used exclusively in veterinary medicine. Spectinomycin is an aminocyclitol antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, primarily acting against certain aerobic gram-negative bacteria and Mycoplasma species. Lincomycin is a lincosamide antibiotic that also inhibits protein synthesis but binds to the 50S ribosomal subunit; it is mainly active against gram-positive bacteria and some anaerobic gram-negative bacteria as well as Mycoplasma species. The combination provides additive or sometimes synergistic antibacterial effects and is indicated for the treatment and prevention of respiratory tract infections (such as chronic respiratory disease in poultry), swine dysentery caused by Serpulina (Treponema) hyodysenteriae, proliferative enteropathy due to Lawsonia intracellularis in pigs, foot rot in sheep caused by Bacteroides nodosus, and other susceptible infections in livestock[1][3][4][5][7]. It is administered orally via drinking water or feed premix for pigs and poultry or by injection for other animals.

Brand names
Linco-SpectinLycinCareInterspectin-L WS
Other names
lincomycin + spectinomycinlincomycin hydrochloride and spectinomycin hydrochloride combination
02

Targets

Bacterial 50S ribosomal subunitBacterial Ribosome

Beyond the preview

Go deeper on spectinomycin + lincomycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on spectinomycin + lincomycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call